Galenica supports and guides their partners in their pharmaceutical development programmes. Galenica is an expert at pharmaceutical and analytical development and production of Clinical Trial Material (CTM) for Phase I – III.

Galenica also manufactures commercially niched products for the market. Galenica is authorized and audited by the Swedish Medical Product Agency for the cGMP production of Clinical Trial Material. Galenica actively develops and launches pharmaceutical drugs to the market, utilizing our state-of-the-art expertise in drug formulation, manufacturing and quality control.